nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—colon cancer	0.335	0.515	CiPCiCtD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—colon cancer	0.315	0.485	CiPCiCtD
Cytarabine—CDA—Capecitabine—colon cancer	0.161	0.615	CbGbCtD
Cytarabine—SLC29A1—Fluorouracil—colon cancer	0.0459	0.175	CbGbCtD
Cytarabine—ABCC10—Vincristine—colon cancer	0.0319	0.122	CbGbCtD
Cytarabine—ABCC10—Methotrexate—colon cancer	0.0193	0.0738	CbGbCtD
Cytarabine—CYP3A4—Irinotecan—colon cancer	0.00204	0.00778	CbGbCtD
Cytarabine—CYP3A4—Vincristine—colon cancer	0.00178	0.0068	CbGbCtD
Cytarabine—DCTD—smooth muscle tissue—colon cancer	0.000832	0.0282	CbGeAlD
Cytarabine—POLB—lymphoid tissue—colon cancer	0.000825	0.0279	CbGeAlD
Cytarabine—NT5E—embryo—colon cancer	0.000819	0.0277	CbGeAlD
Cytarabine—POLD1—renal system—colon cancer	0.000812	0.0275	CbGeAlD
Cytarabine—POLE—embryo—colon cancer	0.000802	0.0271	CbGeAlD
Cytarabine—DCTD—renal system—colon cancer	0.000801	0.0271	CbGeAlD
Cytarabine—POLB—bone marrow—colon cancer	0.000751	0.0254	CbGeAlD
Cytarabine—POLB—vagina—colon cancer	0.00072	0.0244	CbGeAlD
Cytarabine—DCK—Topotecan—Irinotecan—colon cancer	0.000711	0.571	CbGdCrCtD
Cytarabine—POLD1—lymphoid tissue—colon cancer	0.000674	0.0228	CbGeAlD
Cytarabine—NT5E—epithelium—colon cancer	0.000668	0.0226	CbGeAlD
Cytarabine—POLD1—digestive system—colon cancer	0.000666	0.0225	CbGeAlD
Cytarabine—DCTD—digestive system—colon cancer	0.000657	0.0222	CbGeAlD
Cytarabine—NT5E—smooth muscle tissue—colon cancer	0.000644	0.0218	CbGeAlD
Cytarabine—NT5E—renal system—colon cancer	0.00062	0.021	CbGeAlD
Cytarabine—POLB—liver—colon cancer	0.000607	0.0205	CbGeAlD
Cytarabine—DCTD—bone marrow—colon cancer	0.000606	0.0205	CbGeAlD
Cytarabine—CDA—lymphoid tissue—colon cancer	0.000605	0.0205	CbGeAlD
Cytarabine—DCTD—vagina—colon cancer	0.00058	0.0196	CbGeAlD
Cytarabine—CDA—bone marrow—colon cancer	0.000551	0.0186	CbGeAlD
Cytarabine—POLA1—Vinblastine—Vincristine—colon cancer	0.000535	0.429	CbGdCrCtD
Cytarabine—CDA—vagina—colon cancer	0.000528	0.0179	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—colon cancer	0.000515	0.0174	CbGeAlD
Cytarabine—POLE—lymphoid tissue—colon cancer	0.000504	0.0171	CbGeAlD
Cytarabine—POLE—digestive system—colon cancer	0.000498	0.0168	CbGeAlD
Cytarabine—POLD1—liver—colon cancer	0.000496	0.0168	CbGeAlD
Cytarabine—DCTD—liver—colon cancer	0.000489	0.0166	CbGeAlD
Cytarabine—NT5E—bone marrow—colon cancer	0.000469	0.0159	CbGeAlD
Cytarabine—POLB—lymph node—colon cancer	0.000466	0.0158	CbGeAlD
Cytarabine—POLE—bone marrow—colon cancer	0.000459	0.0155	CbGeAlD
Cytarabine—NT5E—vagina—colon cancer	0.000449	0.0152	CbGeAlD
Cytarabine—CDA—liver—colon cancer	0.000445	0.0151	CbGeAlD
Cytarabine—POLE—vagina—colon cancer	0.00044	0.0149	CbGeAlD
Cytarabine—Gemcitabine—TYMS—colon cancer	0.000439	0.445	CrCbGaD
Cytarabine—DCK—embryo—colon cancer	0.000426	0.0144	CbGeAlD
Cytarabine—POLA1—bone marrow—colon cancer	0.000396	0.0134	CbGeAlD
Cytarabine—SLC22A2—renal system—colon cancer	0.000389	0.0132	CbGeAlD
Cytarabine—POLD1—lymph node—colon cancer	0.00038	0.0129	CbGeAlD
Cytarabine—POLA1—vagina—colon cancer	0.000379	0.0128	CbGeAlD
Cytarabine—NT5E—liver—colon cancer	0.000379	0.0128	CbGeAlD
Cytarabine—DCTD—lymph node—colon cancer	0.000375	0.0127	CbGeAlD
Cytarabine—POLE—liver—colon cancer	0.000371	0.0125	CbGeAlD
Cytarabine—CDA—lymph node—colon cancer	0.000341	0.0116	CbGeAlD
Cytarabine—SLC29A1—renal system—colon cancer	0.000338	0.0114	CbGeAlD
Cytarabine—Adenosine monophosphate—SRC—colon cancer	0.000336	0.34	CrCbGaD
Cytarabine—POLA1—liver—colon cancer	0.00032	0.0108	CbGeAlD
Cytarabine—SLC22A2—digestive system—colon cancer	0.000319	0.0108	CbGeAlD
Cytarabine—ABCC10—renal system—colon cancer	0.000307	0.0104	CbGeAlD
Cytarabine—NT5E—lymph node—colon cancer	0.00029	0.00982	CbGeAlD
Cytarabine—POLE—lymph node—colon cancer	0.000284	0.00962	CbGeAlD
Cytarabine—SLC29A1—lymphoid tissue—colon cancer	0.00028	0.00949	CbGeAlD
Cytarabine—SLC29A1—digestive system—colon cancer	0.000277	0.00937	CbGeAlD
Cytarabine—SLC22A1—renal system—colon cancer	0.000275	0.00931	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TYMS—colon cancer	0.000273	0.00486	CbGpPWpGaD
Cytarabine—DCK—lymphoid tissue—colon cancer	0.000268	0.00906	CbGeAlD
Cytarabine—DCK—digestive system—colon cancer	0.000265	0.00895	CbGeAlD
Cytarabine—SLC29A1—bone marrow—colon cancer	0.000255	0.00864	CbGeAlD
Cytarabine—ABCC10—lymphoid tissue—colon cancer	0.000255	0.00863	CbGeAlD
Cytarabine—POLD1—DNA Repair—MUTYH—colon cancer	0.000253	0.0045	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000252	0.00448	CbGpPWpGaD
Cytarabine—ABCC10—digestive system—colon cancer	0.000252	0.00853	CbGeAlD
Cytarabine—POLA1—lymph node—colon cancer	0.000245	0.00829	CbGeAlD
Cytarabine—SLC29A1—vagina—colon cancer	0.000245	0.00827	CbGeAlD
Cytarabine—POLE—DNA Repair—MUTYH—colon cancer	0.000244	0.00434	CbGpPWpGaD
Cytarabine—DCK—bone marrow—colon cancer	0.000244	0.00825	CbGeAlD
Cytarabine—SLC22A2—Abacavir transport and metabolism—ABCB1—colon cancer	0.000241	0.00428	CbGpPWpGaD
Cytarabine—DCK—vagina—colon cancer	0.000234	0.0079	CbGeAlD
Cytarabine—ABCC10—bone marrow—colon cancer	0.000232	0.00786	CbGeAlD
Cytarabine—POLD1—DNA Repair—PMS2—colon cancer	0.000231	0.00411	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000228	0.00406	CbGpPWpGaD
Cytarabine—SLC22A1—Abacavir transport and metabolism—ABCB1—colon cancer	0.000225	0.00399	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—PMS2—colon cancer	0.000223	0.00397	CbGpPWpGaD
Cytarabine—ABCC10—vagina—colon cancer	0.000223	0.00753	CbGeAlD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000222	0.00395	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CA7—colon cancer	0.000218	0.00387	CbGpPWpGaD
Cytarabine—NT5E—Nucleotide metabolism—TYMS—colon cancer	0.000217	0.00385	CbGpPWpGaD
Cytarabine—SLC29A1—liver—colon cancer	0.000206	0.00698	CbGeAlD
Cytarabine—SLC22A1—vagina—colon cancer	0.000199	0.00674	CbGeAlD
Cytarabine—CDA—Nucleotide metabolism—TYMS—colon cancer	0.000198	0.00352	CbGpPWpGaD
Cytarabine—DCK—liver—colon cancer	0.000197	0.00667	CbGeAlD
Cytarabine—POLD1—DNA Repair—MSH6—colon cancer	0.000192	0.00341	CbGpPWpGaD
Cytarabine—ABCC10—liver—colon cancer	0.000188	0.00635	CbGeAlD
Cytarabine—POLE—DNA Repair—MSH6—colon cancer	0.000185	0.00329	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.000168	0.00299	CbGpPWpGaD
Cytarabine—SLC22A1—liver—colon cancer	0.000168	0.00569	CbGeAlD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000163	0.00289	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—colon cancer	0.000158	0.00535	CbGeAlD
Cytarabine—POLD1—DNA Repair—MSH2—colon cancer	0.000155	0.00276	CbGpPWpGaD
Cytarabine—DCK—lymph node—colon cancer	0.000151	0.00511	CbGeAlD
Cytarabine—POLE—DNA Repair—MSH2—colon cancer	0.00015	0.00267	CbGpPWpGaD
Cytarabine—ABCC10—lymph node—colon cancer	0.000144	0.00487	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—VEGFA—colon cancer	0.00014	0.00249	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—MLH1—colon cancer	0.00014	0.00249	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—MLH1—colon cancer	0.000135	0.00241	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ODC1—colon cancer	0.000132	0.00235	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CHST5—colon cancer	0.000132	0.00235	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—colon cancer	0.000131	0.00232	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—TGFB1—colon cancer	0.000129	0.00229	CbGpPWpGaD
Cytarabine—CYP3A4—renal system—colon cancer	0.000125	0.00424	CbGeAlD
Cytarabine—NT5E—Metabolism—CA7—colon cancer	0.000125	0.00222	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000117	0.00209	CbGpPWpGaD
Cytarabine—DCK—Nucleotide metabolism—TYMS—colon cancer	0.000116	0.00205	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000115	0.00204	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CA7—colon cancer	0.000114	0.00203	CbGpPWpGaD
Cytarabine—Gemcitabine—ABCB1—colon cancer	0.000111	0.113	CrCbGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000109	0.00193	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000109	0.00193	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000106	0.00188	CbGpPWpGaD
Cytarabine—CYP3A4—digestive system—colon cancer	0.000103	0.00348	CbGeAlD
Cytarabine—Lamivudine—ABCB1—colon cancer	0.000101	0.103	CrCbGaD
Cytarabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	9.7e-05	0.00172	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—TYMS—colon cancer	9.08e-05	0.00161	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—colon cancer	9.06e-05	0.00161	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MLH3—colon cancer	9.05e-05	0.00161	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—TYMS—colon cancer	8.92e-05	0.00159	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MLH3—colon cancer	8.74e-05	0.00155	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	8.01e-05	0.00142	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	7.75e-05	0.00138	CbGpPWpGaD
Cytarabine—CYP3A4—liver—colon cancer	7.66e-05	0.00259	CbGeAlD
Cytarabine—POLE—Mitotic G1-G1/S phases—TYMS—colon cancer	7.65e-05	0.00136	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ODC1—colon cancer	7.58e-05	0.00135	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CHST5—colon cancer	7.58e-05	0.00135	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CA7—colon cancer	7.1e-05	0.00126	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ODC1—colon cancer	6.93e-05	0.00123	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CHST5—colon cancer	6.93e-05	0.00123	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.93e-05	0.00123	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	6.77e-05	0.0012	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	6.74e-05	0.0012	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CA7—colon cancer	6.68e-05	0.00119	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CCND1—colon cancer	6.67e-05	0.00119	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—TYMS—colon cancer	6.47e-05	0.00115	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CDKN1A—colon cancer	6.45e-05	0.00115	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MLH3—colon cancer	6.23e-05	0.00111	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	5.48e-05	0.000973	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—TYMS—colon cancer	5.45e-05	0.000969	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	5.39e-05	0.000958	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—MYC—colon cancer	5.35e-05	0.000951	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	5.33e-05	0.000948	CbGpPWpGaD
Cytarabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	5.31e-05	0.000943	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	5.3e-05	0.000942	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	5.16e-05	0.000917	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CDKN1A—colon cancer	5.07e-05	0.000901	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1A—colon cancer	4.9e-05	0.00087	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—BUB1B—colon cancer	4.89e-05	0.00087	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1A—colon cancer	4.76e-05	0.000845	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1A—colon cancer	4.59e-05	0.000816	CbGpPWpGaD
Cytarabine—CYP3A4—Irinotecan Pathway—APC—colon cancer	4.47e-05	0.000794	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1A—colon cancer	4.42e-05	0.000786	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—colon cancer	4.39e-05	0.000781	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MYC—colon cancer	4.39e-05	0.000781	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1A—colon cancer	4.34e-05	0.000772	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CHST5—colon cancer	4.3e-05	0.000765	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ODC1—colon cancer	4.3e-05	0.000765	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CCND1—colon cancer	4.3e-05	0.000764	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—colon cancer	4.28e-05	0.00076	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	4.21e-05	0.000748	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1A—colon cancer	4.16e-05	0.000739	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCND1—colon cancer	4.15e-05	0.000738	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—EP300—colon cancer	4.13e-05	0.000735	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	4.13e-05	0.000734	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CHST5—colon cancer	4.04e-05	0.000719	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ODC1—colon cancer	4.04e-05	0.000719	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1A—colon cancer	4.02e-05	0.000714	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MLH1—colon cancer	3.99e-05	0.000709	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.98e-05	0.000707	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	3.9e-05	0.000694	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCND1—colon cancer	3.85e-05	0.000685	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MLH1—colon cancer	3.85e-05	0.000684	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—BUB1B—colon cancer	3.79e-05	0.000674	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	3.77e-05	0.000671	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1A—colon cancer	3.73e-05	0.000663	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—MYC—colon cancer	3.67e-05	0.000652	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BUB1B—colon cancer	3.66e-05	0.000651	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—colon cancer	3.61e-05	0.000641	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—MYC—colon cancer	3.6e-05	0.00064	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—colon cancer	3.51e-05	0.000624	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CDKN1A—colon cancer	3.49e-05	0.00062	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ABCB1—colon cancer	3.49e-05	0.00062	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BUB1B—colon cancer	3.49e-05	0.00062	CbGpPWpGaD
Cytarabine—POLD1—S Phase—MYC—colon cancer	3.45e-05	0.000613	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—TYMS—colon cancer	3.43e-05	0.000609	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ABCB1—colon cancer	3.42e-05	0.000608	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BUB1B—colon cancer	3.39e-05	0.000602	CbGpPWpGaD
Cytarabine—POLE—S Phase—MYC—colon cancer	3.33e-05	0.000592	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BUB1B—colon cancer	3.27e-05	0.000582	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1A—colon cancer	3.27e-05	0.000582	CbGpPWpGaD
Cytarabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.2e-05	0.000569	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—CDKN1A—colon cancer	3.15e-05	0.00056	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	3.13e-05	0.000556	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	3.11e-05	0.000553	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—MYC—colon cancer	3.09e-05	0.000549	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	3.05e-05	0.000542	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.03e-05	0.000539	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CCND1—colon cancer	2.96e-05	0.000526	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TYMS—colon cancer	2.91e-05	0.000517	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDKN1A—colon cancer	2.86e-05	0.000509	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TYMS—colon cancer	2.81e-05	0.000499	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—colon cancer	2.75e-05	0.000488	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MLH1—colon cancer	2.74e-05	0.000488	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.71e-05	0.000482	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—colon cancer	2.66e-05	0.000472	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CA7—colon cancer	2.64e-05	0.00047	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—colon cancer	2.61e-05	0.000465	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BUB1B—colon cancer	2.61e-05	0.000464	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TYMS—colon cancer	2.6e-05	0.000462	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	2.57e-05	0.000457	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TYMS—colon cancer	2.51e-05	0.000446	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CA7—colon cancer	2.46e-05	0.000438	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PPARG—colon cancer	2.43e-05	0.000431	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—colon cancer	2.37e-05	0.000422	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BUB1B—colon cancer	2.33e-05	0.000415	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.3e-05	0.000409	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—colon cancer	2.2e-05	0.000391	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.14e-05	0.00038	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.12e-05	0.000377	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.08e-05	0.00037	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.06e-05	0.000366	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.01e-05	0.000358	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ABCB1—colon cancer	2e-05	0.000356	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TYMS—colon cancer	2e-05	0.000355	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMS—colon cancer	1.97e-05	0.00035	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.91e-05	0.00034	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—colon cancer	1.91e-05	0.000339	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.86e-05	0.000331	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ABCB1—colon cancer	1.83e-05	0.000326	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.81e-05	0.000322	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMS—colon cancer	1.8e-05	0.00032	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TYMS—colon cancer	1.79e-05	0.000318	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.67e-05	0.000297	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.66e-05	0.000296	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.63e-05	0.00029	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CHST5—colon cancer	1.6e-05	0.000285	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ODC1—colon cancer	1.6e-05	0.000285	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—EP300—colon cancer	1.59e-05	0.000282	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.54e-05	0.000274	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ODC1—colon cancer	1.49e-05	0.000265	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CHST5—colon cancer	1.49e-05	0.000265	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	1.49e-05	0.000264	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—colon cancer	1.46e-05	0.00026	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.42e-05	0.000252	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.42e-05	0.000252	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—colon cancer	1.41e-05	0.000251	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPARG—colon cancer	1.39e-05	0.000248	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	1.39e-05	0.000246	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.37e-05	0.000244	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.37e-05	0.000243	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—EP300—colon cancer	1.35e-05	0.000239	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—colon cancer	1.31e-05	0.000233	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—EP300—colon cancer	1.3e-05	0.000231	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPARG—colon cancer	1.27e-05	0.000227	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1A—colon cancer	1.27e-05	0.000225	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—colon cancer	1.26e-05	0.000225	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1A—colon cancer	1.22e-05	0.000217	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—EP300—colon cancer	1.2e-05	0.000214	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—colon cancer	1.17e-05	0.000209	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—colon cancer	1.17e-05	0.000209	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—EP300—colon cancer	1.16e-05	0.000207	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.16e-05	0.000206	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—BRAF—colon cancer	1.14e-05	0.000202	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ABCB1—colon cancer	1.14e-05	0.000202	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—colon cancer	1.13e-05	0.000201	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMS—colon cancer	1.12e-05	0.000198	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—colon cancer	1.1e-05	0.000195	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ABCB1—colon cancer	1.07e-05	0.00019	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—BRAF—colon cancer	1.06e-05	0.000189	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMS—colon cancer	1.05e-05	0.000187	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—colon cancer	1.05e-05	0.000187	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—colon cancer	1.01e-05	0.00018	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—colon cancer	1.01e-05	0.000179	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—colon cancer	1e-05	0.000178	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	9.74e-06	0.000173	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—colon cancer	9.6e-06	0.000171	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—EP300—colon cancer	9.27e-06	0.000165	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—EP300—colon cancer	9.12e-06	0.000162	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	9.04e-06	0.000161	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—colon cancer	9e-06	0.00016	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CA7—colon cancer	8.9e-06	0.000158	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1A—colon cancer	8.71e-06	0.000155	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—colon cancer	8.62e-06	0.000153	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	8.42e-06	0.00015	CbGpPWpGaD
Cytarabine—CDA—Metabolism—EP300—colon cancer	8.34e-06	0.000148	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—colon cancer	8.32e-06	0.000148	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—EP300—colon cancer	8.29e-06	0.000147	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—colon cancer	8.08e-06	0.000144	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPARG—colon cancer	7.91e-06	0.000141	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPARG—colon cancer	7.44e-06	0.000132	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—colon cancer	7.22e-06	0.000128	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	6.83e-06	0.000121	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—colon cancer	6.75e-06	0.00012	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	6.37e-06	0.000113	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—colon cancer	6.22e-06	0.000111	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—colon cancer	6.17e-06	0.00011	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—colon cancer	5.93e-06	0.000105	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—colon cancer	5.85e-06	0.000104	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—colon cancer	5.51e-06	9.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ODC1—colon cancer	5.39e-06	9.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CHST5—colon cancer	5.39e-06	9.58e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—colon cancer	5.24e-06	9.31e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—EP300—colon cancer	5.17e-06	9.2e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—colon cancer	5.04e-06	8.96e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—colon cancer	4.88e-06	8.68e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—EP300—colon cancer	4.86e-06	8.65e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ABCB1—colon cancer	4.23e-06	7.52e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—colon cancer	4.16e-06	7.39e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ABCB1—colon cancer	3.95e-06	7.01e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—colon cancer	3.87e-06	6.89e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—colon cancer	3.83e-06	6.8e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—colon cancer	3.6e-06	6.4e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—colon cancer	3.13e-06	5.56e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPARG—colon cancer	2.94e-06	5.23e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—colon cancer	2.94e-06	5.23e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPARG—colon cancer	2.74e-06	4.88e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—colon cancer	2.32e-06	4.12e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—colon cancer	2.16e-06	3.84e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EP300—colon cancer	1.93e-06	3.42e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EP300—colon cancer	1.8e-06	3.19e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—colon cancer	1.43e-06	2.53e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCB1—colon cancer	1.42e-06	2.53e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—colon cancer	1.4e-06	2.49e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—colon cancer	1.33e-06	2.36e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—colon cancer	1.16e-06	2.07e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—colon cancer	1.09e-06	1.93e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARG—colon cancer	9.91e-07	1.76e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—colon cancer	7.8e-07	1.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EP300—colon cancer	6.48e-07	1.15e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—colon cancer	4.8e-07	8.53e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—colon cancer	3.92e-07	6.97e-06	CbGpPWpGaD
